This experiment mainly optimizes Agaricus Blazei Polipeptide (ABP) extraction technology and evaluates the protection effect on aging mice. In this study, a new single component, M 3 KD, isolated and purified from Agaricus Blazei. The aging mouse model was established using D-galactose. After the ABP administration, the contents of total antioxidant capacity (T-AOC), malondialdehyde (MDA), catalase (cat), and reactive oxygen species changed significantly. Through immunofluorescence staining, observed that ABP can reduce brain tissue changes. The expression of the generation of genes was analyzed by RNA-SEQ.
A total of 295 genes expressed differently filtered in the ABP Gen Group.rt-QPCR verify the important gene and show that the level of MRNA HSPH1, Trim32, HNRNPA1, and Grik5 expression increased significantly, and people from APOE, ATP1A3, STXBP1, and MAPK8IP1 decreased significantly. West Blotting shows that the level of expression of KAPE1 and P53 protein is significantly lower, while the level of protein expression of NRF2, HO-1, HSPH1, and TRIM32 is significantly higher in the ABP group.
ABP plays an anti-aging role in a rat aging model. Specific work mechanisms may be related to the expression regulations of the KAPE1 / NRF2 / P53 signaling path and related factors. Practical application: This research can contribute to the development of ABP as functional food or food supplements for anti-aging in the future.
Carboxyl-terminal polypeptide fragment from MUC16 Combing Stathmin1 promotes migration and bile cancer cell invasion
CA-125, encoded by Gen MUC16, is responsible for various types of tumor metastasis. However, related mechanisms are still unclear. We have set new ways to reveal gallbladder cancer metastasis related to the serum level CA-125 through C-terminal polypeptides from Gen16 production. MUC16 C-terminal polypeptides significantly promote bile cancer cell migration and in vitro invasion. The mass spectrum indicates that the interaction of MUC16 terminal C fragment with the C-STATHmin1 terminal domain inhibits STATHMIN1 phosphorylation to promote combinations with tubulins.
STATHMIN1 Knockdown Inhibits migration and invasion of bile cancer cells in vitro and metastasis in vivo lungs caused by polypeptides Terminal C-terminal MUC16. The level of high expression of MUC16C is consistent with STATHMIN1 is also confirmed in the gallbladder cancer tissue. Our study revealed the mechanism that underlies the gallbladder cancer metastasis related to the level of CA-125, which is useful for CA-125 in the diagnosis and therapy of gallbladder cancer.
Localization of vasoactive polypeptide receptor 1 (VPAC1) in neuroendocrine hypothalamic neuroendocrine neurons; Potential role in circadian prolactin secretion
Prolactin (PRL) is a versatile hormone and presents various physiological functions other than lactation. The release of the PRL from lactotrof in the hypophysis owned in mice is proven to be released with a circadian pattern depending on the physiological state of the animal. The release of the Circadian PRL seems to be a complex involving tonic inhibition by dopamine (DA) neurons in lactotrof and one or even several release factors. Because of the pattern of release of circadian PRL, neurons in the suprachiasmatic nucleus (SCN), “brain clock,” and especially neurons that express neuropeptide vasoactive polypeptide intestine (VIP), have been advised to be involved in the circadian regulation.

In this study, we use immunohistochemical fluorescence, in hybridization histochemistry situ, confocal microscope, three-dimensional reconstruction, and very specific antibodies to visualize the occurrence of VIP 1 and 2 receptors (VPAC1 and VPAC2) in the stained mouse hypothalamic section in combination with VIP , Oxytocin (OXT), Arginine Vasopresin (AVP), and DA (Tyrosine hydroxylase, th). We show that VIP fiber is likely to come from the ventral part of the SCN project to OXT neurons in the magnocelluler part of nucleus paraventricular (PVN).
In PVN, VIP fibers found in the application close to Oxt Neurons exclusively express VPAC1 receptors. Next, we show that Oxt neurons or AVP neurons do not express VPAC2 receptors. The expression of VPAC receptors is also found in blood vessels but not in neurons that express AVP or th. These findings indicate that VIP signaling from the SCN does not directly target neurons involved in the PLL secretion. Furthermore, the findings support the idea that the VIP from neurons in the SCN can regulate the release of circadian oxt in pituitary neurons or posterior modulation as the release factor involved in the temperature regulation of lactotrof.
Pancreas polypeptides but not other members of the Neuropeptide Y family show a moderate relationship with anxiety felt in a fat man
Neuropeptide Y (NPY), Peptide Tyrosine Tyrosine (PYY), and Pancreatic Polypeptide (PP) is an important mediator in two-way communication along the intestinal axis. Most famous for their role in taste rules and their food intake is considered to play an important role in the development of obesity. In addition, evidence of installation shows regulatory functions in anxiety, mood and stress resistance with gender potential differences. In this study, we examined the association of NPY, PYY, and PP plasma levels with anxiety, depression and stress felt in obesity patients.
We analyzed 144 inpatients (90 women, 54 men, BMI: 49.4 kg / m2) in naturalistic care settings for obesity and somatic and mental comorbidity. Fasting blood samples were taken, and the patient completed the psychometric self-assessment questionnaire (GAD-7, PHQ-9, PSQ-20) in the first week after entering and before exiting. The plasma concentration of peptides was measured by Elisa. Women showed higher anxiety (GAD-7: 8.13 ± 5.67 vs 5.93 ± 5.42, p = 0.04) and stress scores (PSQ-20: 52.62 ± 23.5 vs 41.23 ± 0.01 ) than men. In the longitudinal analysis of women with increasing clinically relevant anxiety (≥ 5 points at GAD-7, P <0.001) also showed a significant increase in depression (PHQ-9: 38%, p = 0.002) and PSQ-20 score (23) %, p = 0.005) while male patients who enhanced anxiety only increased in the tension of the PSQ-20 subscale (34%, p = 0.02).
In the man we observed the positive correlation of PP with anxiety scores (GAD-7: R = 0.41, p = 0.007) and with age (r = 0.49, p = 0.001) when entered while NPY correlated negatively with age (r = -0.38), p = 0.01). Instead, there was no significant association (P> 0.05) on the subject of women in cross-sectional and in longitudinal analysis. In conclusion, women who suffer from terrible obesity show greater psychological comorbidity and considerable interaction between them.
PTCHD2 Peptide |
MBS153120-5x005mg |
MyBiosource |
5x0.05mg |
EUR 770 |
PTCHD1 Peptide |
42-686P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: (IN) PTCHD1 Peptide |
PTCHD3 Peptide |
43-006P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: PTCHD3 Peptide |
PTCHD1 Immunizing Peptide |
MBS427529-01mg |
MyBiosource |
0.1mg |
EUR 225 |
PTCHD3 Immunizing Peptide |
MBS427798-01mg |
MyBiosource |
0.1mg |
EUR 225 |
PTCHD2 Antibody |
6637-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
6637-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
25404 |
SAB |
100ul |
EUR 479 |
PTCHD2 Antibody |
25404-100ul |
SAB |
100ul |
EUR 468 |
PTCHD2 Antibody |
24792 |
SAB |
100ul |
EUR 479 |
PTCHD2 Antibody |
24792-100ul |
SAB |
100ul |
EUR 468 |
PTCHD2 Antibody |
24797 |
SAB |
100ul |
EUR 479 |
PTCHD2 Antibody |
24797-100ul |
SAB |
100ul |
EUR 468 |
PTCHD2 Antibody |
4915-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
4915-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
4925-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
4925-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
MBS151200-01mg |
MyBiosource |
0.1mg |
EUR 445 |
PTCHD2 Antibody |
MBS151200-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
PTCHD2 Antibody |
MBS151575-01mg |
MyBiosource |
0.1mg |
EUR 445 |
PTCHD2 Antibody |
MBS151575-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
PTCHD2 Antibody |
MBS151579-01mg |
MyBiosource |
0.1mg |
EUR 445 |
PTCHD2 Antibody |
MBS151579-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1965 |
PTCHD2 Antibody |
MBS9410982-01mL |
MyBiosource |
0.1mL |
EUR 495 |
PTCHD2 Antibody |
MBS9410982-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
PTCHD2 Antibody |
MBS9407915-01mL |
MyBiosource |
0.1mL |
EUR 495 |
PTCHD2 Antibody |
MBS9407915-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
PTCHD2 Antibody |
MBS9408772-01mL |
MyBiosource |
0.1mL |
EUR 495 |
PTCHD2 Antibody |
MBS9408772-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2075 |
Ptchd2 (untagged) - Mouse patched domain containing 2 (Ptchd2), (10ug) |
MC224316 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Human PTCHD2 siRNA |
20-abx930257 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
PTCHD2 siRNA (Human) |
MBS8237840-15nmol |
MyBiosource |
15nmol |
EUR 405 |
PTCHD2 siRNA (Human) |
MBS8237840-30nmol |
MyBiosource |
30nmol |
EUR 565 |
PTCHD2 siRNA (Human) |
MBS8237840-5x30nmol |
MyBiosource |
5x30nmol |
EUR 2450 |
PTCHD1 Antibody (Center) Blocking peptide |
MBS9218358-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
PTCHD3 Antibody (C-term) Blocking peptide |
MBS9218367-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Ptchd2 (GFP-tagged) - Mouse patched domain containing 2 (Ptchd2), (10ug) |
MG223294 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Polyclonal PTCHD2 Antibody |
AMR09590G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PTCHD2 Antibody |
AMR09591G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PTCHD2 Antibody |
AMR09592G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
PTCHD2 Polyclonal Antibody |
MBS9234398-01mL |
MyBiosource |
0.1mL |
EUR 415 |
PTCHD2 Polyclonal Antibody |
MBS9234398-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
Human PTCHD2 shRNA Plasmid |
20-abx961520 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Lenti ORF clone of Ptchd2 (mGFP-tagged) - Mouse patched domain containing 2 (Ptchd2) |
MR223294L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
AAP94899-100UG - Ptchd3 Blocking peptide (N terminal region) |
AAP94899-100UG |
Aviva Systems Biology |
100ug |
EUR 99 |
|
PTCHD2 ORF Vector (Human) (pORF) |
ORF028512 |
ABM |
1.0 ug DNA |
Ask for price |
Ptchd2 ORF Vector (Mouse) (pORF) |
ORF055152 |
ABM |
1.0 ug DNA |
EUR 1886.4 |
Lenti ORF clone of Ptchd2 (Myc-DDK-tagged) - Mouse patched domain containing 2 (Ptchd2) |
MR223294L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Human PTCHD2 knockout cell line |
ABC-KH12357 |
AcceGen |
1 vial |
Ask for price |
Description: Human PTCHD2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human PTCHD2 knockdown cell line |
ABC-KD12357 |
AcceGen |
1 vial |
Ask for price |
Description: Human PTCHD2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401 |
004-04 |
PHOENIX PEPTIDE |
100 μg |
EUR 140.4 |
Polyclonal PTCHD2 Antibody (N-Terminus) |
AMR09593G |
Leading Biology |
0.05mg |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 (N-Terminus). This antibody is tested and proven to work in the following applications: |
Lenti ORF particles, Ptchd2 (GFP-tagged) - Mouse patched domain containing 2 (Ptchd2), 200ul, >10^7 TU/mL |
MR223294L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, PTCHD2 (mGFP-tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL |
RC211355L2V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, PTCHD2 (mGFP-tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL |
RC211355L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, PTCHD2 (Myc-DDK tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL |
RC211355L1V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, PTCHD2 (Myc-DDK tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL |
RC211355L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Lenti ORF particles, Ptchd2 (Myc-DDK-tagged) - Mouse patched domain containing 2 (Ptchd2), 200ul, >10^7 TU/mL |
MR223294L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Ptchd2 3'UTR GFP Stable Cell Line |
TU167223 |
ABM |
1.0 ml |
Ask for price |
PTCHD2 3'UTR GFP Stable Cell Line |
TU069132 |
ABM |
1.0 ml |
EUR 1672.8 |
PTCHD2 sgRNA CRISPR Lentivector set (Human) |
K1748901 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Ptchd2 sgRNA CRISPR Lentivector set (Mouse) |
K3185201 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
PTCHD2 Protein Vector (Human) (pPM-C-HA) |
PV114048 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Mouse) (pPM-C-HA) |
PV220608 |
ABM |
500 ng |
EUR 2766 |
PTCHD2 Protein Vector (Human) (pPB-C-His) |
PV114046 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPB-N-His) |
PV114047 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPM-C-His) |
PV114049 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Mouse) (pPB-C-His) |
PV220606 |
ABM |
500 ng |
EUR 2766 |
PTCHD2 Protein Vector (Mouse) (pPB-N-His) |
PV220607 |
ABM |
500 ng |
EUR 2766 |
PTCHD2 Protein Vector (Mouse) (pPM-C-His) |
PV220609 |
ABM |
500 ng |
EUR 2766 |
Ptchd2 3'UTR Luciferase Stable Cell Line |
TU117223 |
ABM |
1.0 ml |
Ask for price |
PTCHD2 3'UTR Luciferase Stable Cell Line |
TU019132 |
ABM |
1.0 ml |
EUR 1672.8 |
Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine) |
024-57 |
PHOENIX PEPTIDE |
200 μg |
EUR 86.4 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 1) |
K1748902 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 2) |
K1748903 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 3) |
K1748904 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3185202 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3185203 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3185204 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide |
007-60 |
PHOENIX PEPTIDE |
100 μg |
EUR 214.92 |
GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human) |
029-03 |
PHOENIX PEPTIDE |
500 μg |
EUR 114.48 |
GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human) |
029-04 |
PHOENIX PEPTIDE |
100 μg |
EUR 114.48 |
GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human) |
029-05 |
PHOENIX PEPTIDE |
20 μg |
EUR 267.84 |
GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human) |
029-06 |
PHOENIX PEPTIDE |
100 μg |
EUR 114.48 |
GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat) |
029-08 |
PHOENIX PEPTIDE |
200 μg |
EUR 64.8 |
Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog) |
048-80 |
PHOENIX PEPTIDE |
500 μg |
EUR 177.12 |
Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog) |
048-81 |
PHOENIX PEPTIDE |
200 μg |
EUR 214.92 |
Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog) |
048-82 |
PHOENIX PEPTIDE |
200 μg |
EUR 214.92 |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) |
064-01 |
PHOENIX PEPTIDE |
200 μg |
EUR 108 |
proSex peptide (28-55) - EIA Kit |
EK-040-31 |
PHOENIX PEPTIDE |
96 wells |
EUR 603.72 |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) |
064-07 |
PHOENIX PEPTIDE |
200 μg |
EUR 114.48 |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana) |
047-39 |
PHOENIX PEPTIDE |
200 μg |
EUR 444.96 |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana) |
047-40 |
PHOENIX PEPTIDE |
500 μg |
EUR 214.92 |
Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica) |
047-42 |
PHOENIX PEPTIDE |
200 μg |
EUR 444.96 |
Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica) |
047-43 |
PHOENIX PEPTIDE |
500 μg |
EUR 214.92 |
Cell Penetrating ARF Peptide (26-44) |
068-56 |
PHOENIX PEPTIDE |
500 μg |
EUR 640.44 |
Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - RIA Kit |
RK-064-01 |
PHOENIX PEPTIDE |
125 tubes |
EUR 932.04 |
Gastrointestinal Peptide Library |
L-006 |
PHOENIX PEPTIDE |
200 peptides |
EUR 7267.32 |
[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide |
033-34 |
PHOENIX PEPTIDE |
100 μg |
EUR 177.12 |
Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody |
H-064-07 |
PHOENIX PEPTIDE |
50 μl |
EUR 238.68 |
Peptide F (Bovine) - RIA Kit |
RK-024-58 |
PHOENIX PEPTIDE |
125 tubes |
EUR 932.04 |
Even though we only observed the PP association with anxiety and age with NPY and PP in men, suggesting the possibility of the effect of sex hormones on the NPY system. However, an increase in anxiety scores does not lead to significant changes in NPY.